Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve It is hereby informed that a meeting of the Board of directors of the Company will be held on Thursday, 29th october 2026, inter-alia, to consider and approve, the unaudited financial results for the quater ended 30-09-2026.

Indraprastha Medical Corporation Limited (Indraprastha Apollo Hospitals) Regd. Office : Sarita Vihar, Delhi-Mathura Road, New Delhi – 110 076 (India) Corporate Identity Number : L24232DL1988PLC030958 Phone:91-11-26925858,26925801,Fax: 91-11-26823629 E-mail: imclshares@apollohospitals.com, Website : https://www.apollohospitals.com/delhi/ Ref: IMCL/CS/BM/2026 19th October, 2026 The Manager The Manager Listing Department Listing Department BSE Limited Phiroze Jeejeebhoy National Stock Exchange of India Limite Exchange Plaza, C-1, Block G, Towers Dalal Street, Mumbai, Bandra Kurla Complex, Bandra East, Maharashtra - 400001 Mumbai, Maharashtra – 400051 Scrip Code: 532150 Symbol: INDRAMEDCO Dear Sir, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Thursday, 29th October, 2026, inter-alia, to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2026. This is for your information and record. Thanking You, Sincerely Yours, For Indraprastha Medical Corporation Limited Priya Ranjan AVP – Corporate Affairs & Legal (Company Secretary & Compliance Officer)